Skip to main content

Advertisement

Log in

Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

The effects of right ventricular (RV) lead location and the combination of RV and left ventricular (LV) lead locations on long-term outcomes in patients receiving cardiac resynchronization therapy with defibrillator (CRT-D) are not well understood.

Methods

Our cohort consisted of 743 CRT-D patients from MADIT-CRT. We evaluated long-term death and combined heart failure or death (HF/death) in patients with non-apical RV vs. apical RV leads. We further assessed these long-term outcomes based on the combination of RV and LV leads, termed “RV-LV lead interaction.” Patients with non-apical RV and apical LV leads and those with apical RV and non-apical LV leads were described to have “discordant RV and LV leads.” Patients with RV and LV leads that were both non-apical or both apical were defined to have “concordant RV and LV leads.”

Results

There were no differences in death and HF/death between patients with non-apical RV vs. apical RV leads. However, patients with non-apical RV and apical LV leads had higher mortality risk, relative to those with apical RV and non-apical LV leads (HR = 4.06, 95% CI 1.73–9.53, p = 0.001) as well as those with both leads in the non-apical (HR = 3.82, 95% CI 1.33–10.98, p = 0.013) or apical (HR = 3.40, 95% CI 1.24–9.37, p = 0.018) positions. There was no difference in HF/death by RV-LV lead sub-groups.

Conclusion

Among CRT-D patients, long-term outcomes were similar for non-apical RV and apical RV leads. However, mortality risk was increased with discordant RV and LV leads, when a non-apical RV lead was combined with an apical LV lead.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.

    Article  PubMed  CAS  Google Scholar 

  2. Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.

    Article  PubMed  CAS  Google Scholar 

  3. Linde C, Abraham WT, Gold MR, Sutton MSJ, Ghio S, Daubert C, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834–43.

    Article  PubMed  Google Scholar 

  4. Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, et al. Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10:34–43.

    Article  PubMed  Google Scholar 

  5. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329–38.

    Article  PubMed  Google Scholar 

  6. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385–95.

    Article  PubMed  CAS  Google Scholar 

  7. Goldenberg I, Kutyifa V, Klein HU, Cannom DS, Brown MW, Dan A, et al. Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med. 2014;370:1694–701.

    Article  PubMed  CAS  Google Scholar 

  8. Cleland JG, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27:1928–32.

    Article  PubMed  Google Scholar 

  9. Riedlbauchová L, Cihák R, Bytesník J, Vancura V, Frídl P, Hosková L, et al. Optimization of right ventricular lead position in cardiac resynchronisation therapy. Eur J Heart Fail. 2006;8:609–14.

    Article  PubMed  Google Scholar 

  10. Miranda R, Nault M, Johri A, Simpson C, Michael K, Abdollah H, et al. Maximal electric separation-guided placement of right ventricular lead improves responders in cardiac resynchronization defibrillator therapy. Circ Arrhythm Electrophysiol. 2012;5:927–32.

    Article  PubMed  Google Scholar 

  11. Miranda RI, Nault M, Simpson CS, Michael KA, Abdollah H, Baranchuk A, et al. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing. J Cardiovasc Electrophysiol. 2012;23:370–4.

    Article  PubMed  Google Scholar 

  12. Khan FZ, Salahshouri P, Duehmke R, Read PA, Pugh PJ, Elsik M, et al. The impact of the right ventricular lead position on response to cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2011;34:467–74.

    Article  PubMed  Google Scholar 

  13. Kristiansen H, Vollan G, Hovstad T, Keilegavlen H, Faerestrand S. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy. Eur J Heart Fail. 2012;14:506–16.

    Article  PubMed  CAS  Google Scholar 

  14. Thébault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR, et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J. 2012;33:2662–71.

    Article  PubMed  Google Scholar 

  15. Kutyifa V, Thomsen PEB, Huang DT, Rosero S, Tompkins C, Jons C, et al. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Heart Rhythm. 2013;10:1770–7.

    Article  PubMed  Google Scholar 

  16. Asbach S, Lennerz C, Semmler V, Grebmer C, Solzbach U, Kloppe A, et al. Impact of the right ventricular lead position on clinical end points in CRT recipients—a subanalysis of the multicenter randomized SPICE trial. Pacing Clin Electrophysiol. 2016;39:261–7.

    Article  PubMed  Google Scholar 

  17. Leclercq C, Sadoul N, Mont L, Defaye P, Osca J, Mouton E, et al. Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study. Eur Heart J. 2016;37:473–83.

    Article  PubMed  Google Scholar 

  18. Zografos TA, Siontis KC, Jastrzebski M, Kutyifa V, Klein HU, Zareba W, et al. Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis. Europace. 2015;17:1259–66.

    Article  PubMed  Google Scholar 

  19. Merchant F, Heist E, McCarty D, Kumar P, Das S, Blendea D, et al. Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm. 2010;7:639.

    Article  PubMed  Google Scholar 

  20. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) TrialClinical perspective. Circulation. 2011;123:1159–66.

    Article  PubMed  Google Scholar 

  21. Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, Goldenberg I, Huang DT, Merkely B and Wang PJ. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2012;ehs334.

  22. Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.

    Article  PubMed  Google Scholar 

  23. Knappe D, Pouleur A-C, Shah AM, Cheng S, Uno H, Hall WJ, et al. Dyssynchrony, contractile function, and response to cardiac resynchronization TherapyClinical perspective. Circ Heart Fail. 2011;4:433–40.

    Article  PubMed  Google Scholar 

  24. Pouleur A-C, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, et al. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011;32:1720–9.

    Article  PubMed  Google Scholar 

  25. Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, et al. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure. Europace. 2009;11:356–63.

    Article  PubMed  Google Scholar 

  26. Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith RE, Jordan PJ, et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol. 2007;50:243–52.

    Article  PubMed  Google Scholar 

  27. Kutyifa V, Pouleur A-C, Knappe D, Al-Ahmad A, Gibinski M, Wang PJ, et al. Dyssynchrony and the risk of ventricular arrhythmias. J Am Coll Cardiol Img. 2013;6:432–44.

    Article  Google Scholar 

Download references

Funding

The MADIT-CRT study was supported by a research grant from Boston Scientific to the University of Rochester.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valentina Kutyifa.

Ethics declarations

Conflict of interest

Drs. Klein, Zareba, Moss, and Kutyifa have received research grants from Boston Scientific.

Ethical approval

Institutional review boards approved both MADIT-CRT and the post-trial follow-up studies, and all subjects gave informed consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Daimee, U.A., Klein, H.U., Giudici, M.C. et al. Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients. J Interv Card Electrophysiol 52, 185–194 (2018). https://doi.org/10.1007/s10840-018-0332-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-018-0332-4

Keywords

Navigation